Tech Company Financing Transactions
Swift Biosciences Funding Round
Swift Biosciences closed a $2.9 million funding round on 1/31/2017. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/31/2017
Transaction Type
Debt
Amount
$2,907,422
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 28 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
674 S. Wagner Rd. 100
Ann Arbor, MI 48103
USA
Ann Arbor, MI 48103
USA
Phone
Website
Email Address
Overview
Swift Biosciences is developing molecular biology reagents for research and diagnostic applications.Our products help users to detect genes and gene products that other products can't. We also help users to analyze their samples faster, at higher volume, and at a lower price-per-sample.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nathan Wood
Chief Financial Officer
James Militello
Chief Scientific Officer
Vladimir Makarov
VP - Marketing
Camille Cappello
VP - Product Management
Laurie Kurihara
VP - Sales
Haley Fiske
Browse more venture capital transactions:
Prev: 1/31/2017: Sproxil venture capital transaction
Next: 1/31/2017: The Bouqs venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs